Clinical trial
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally…
NCT00416767 · Federation Francophone de Cancerologie Digestive, Other · Completed
Key facts
| NCT number | NCT00416767 |
|---|---|
| Title | Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery |
| Official title | Study of First-Line Therapy Comprising Leucovorin Calcium, Fluorouracil, and Irinotecan (FOLFIRI) in Patients With Progressive Locally Advanced or Metastatic Duodenal-Pancreatic Endocrine Tumors |
| Lead sponsor | Federation Francophone de Cancerologie Digestive, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome |
| Intervention type | Drug |
| Interventions | fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Enrollment | 20 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Dec 28, 2006 |
| Last update posted | May 30, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: